miércoles, 17 de enero de 2024

Phase 3 trial shows acoramidis safe and effective for transthyretin amyloid cardiomyopathy

https://www.news-medical.net/news/20240116/Phase-3-trial-shows-acoramidis-safe-and-effective-for-transthyretin-amyloid-cardiomyopathy.aspx

No hay comentarios:

Publicar un comentario